Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Axel Unterbeck is active.

Publication


Featured researches published by Axel Unterbeck.


Cellular Signalling | 2003

Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7.

Daguang Wang; Chengjun Deng; Bozena Bugaj-Gaweda; May Kwan; Caryn Gunwaldsen; Chris Leonard; Xiaonan Xin; Yinghe Hu; Axel Unterbeck; Michael De Vivo

We report here the cloning and characterization of two novel PDE4D isoforms, PDE4D6 and PDE4D7. PDE4D6 is a supershort form and PDE4D7 a long form of PDE4D. In addition, we have identified another novel long-form variant, PDE4D8, in silico. Like other isoforms, PDE4D6 and PDE4D7 are differentially expressed. Expression of PDE4D6 is restricted to brain whereas PDE4D7 is widely expressed in many tissues. Baculovirus-expressed recombinant PDE4D6 and PDE4D7 enzymes have high affinity for cyclic AMP (cAMP) and are inhibited by rolipram. The activity of PDE4D7, not PDE4D6, is elevated by a protein kinase A (PKA)-dependent mechanism, presumably through phosphorylation of the conserved PKA site in the upstream conserved region 1 (UCR1) domain. In agreement with early reports, human PDE4D6 and PDE4D7 are localized on genomic fragments of chromosome 5. Examination of the promoter regions reveals multiple CREB binding sites upstream of the starting methionine (Met) of each gene, suggesting that the cAMP/PKA signaling pathway may regulate transcriptional expression of PDE4D6 and PDE4D7.


American Journal of Respiratory and Critical Care Medicine | 2004

Phosphodiesterase 4 inhibitors

Richard Schumacher; William Frederick Brubaker; Michael De Vivo; Hans-Jurgen Ernst Hess; Allen Hopper; Ashok Tehim; Ruiping Liu; Axel Unterbeck


Archive | 2003

Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs

Richard Schumacher; Allen Hopper; Ashok Tehim; Hans-Jurgen Ernst Hess; Axel Unterbeck; Erik Kuester; William Frederick Brubaker; Robert Dunn


Archive | 2002

Aniline derivatives useful as phosphodiesterase 4 inhibitors

Allen Hopper; Richard Schumacher; Ashok Tehim; Vivo Michael De; William Frederick Brubaker; Ruiping Liu; Hans-Jurgen Ernst Hess; Axel Unterbeck


Archive | 2000

Cyclic AMP phosphodiesterase isoforms and methods of use

Xiaonan Xin; Axel Unterbeck; Yinghe Hu


Archive | 2004

Using of (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dymethyl-pyridine-3,5-dicarboxylate in the treatment of memory disorders

Axel Unterbeck; Vivo Michael De; Gregory M. Rose


Genesis | 2002

Conditional inactivation of the dopamine receptor 5 gene: flanking the Drd5 gene with loxP sites.

Joerg Heyer; Qiurong Xiao; Bozena Bugaj-Gaweda; Sylvie Ramboz; Axel Unterbeck


Archive | 2008

Methods of treatment using (+)- isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2, 6-dimethyl-pyridine-3, 5-dicarboxylate

Axel Unterbeck; Michael De Vivo; Gregory M. Rose


Drug Discovery Today | 2005

Axel Unterbeck on memory, cognition and the development of CNS drugs

Steve Carney; Axel Unterbeck


Archive | 2004

Zusammensetzungen und Verfahren zur Behandlung mithilfe von L-Kalzium-Kanalblockern und Cholinesterase-Inhibitoren

Christa Murphy; Gregory M. Rose; Axel Unterbeck

Collaboration


Dive into the Axel Unterbeck's collaboration.

Researchain Logo
Decentralizing Knowledge